To include your compound in the COVID-19 Resource Center, submit it here.

AGN 195795 (AC-170472): Began Phase I/IIa testing

Acadia Pharmaceuticals Inc., San Diego, Calif.
Product: AGN 195795

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE